Registry study of the Myval heart valve for severe aortic stenosis
Part of Heart & circulation clinical trials.
This study is tracking how well the Myval valve works in people with severe aortic stenosis who get it through a minimally invasive procedure called TAVI. It helps doctors learn more about the valve's safety and performance in real-world use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have severe aortic stenosis (a narrowed heart valve).
- Your heart team must have decided that a TAVI procedure with the Myval valve is right for you.
- You need to be willing to sign a consent form and attend all follow-up visits.
- You cannot have allergies to certain medicines or metals used in the valve or procedure.
- You cannot have an active heart infection, liver failure, or be pregnant or nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether the Myval THV (a new heart valve) is safe and effective for adults who need TAVI, a procedure to replace a narrowed heart valve without open-heart surgery. You may be considered if a heart team says you’re a good candidate for this valve procedure and you’re willing to join the study.
This registry tracks people getting a new heart valve called Myval. It's designed to see how well it works in real-world care.
This study looks at how well a new valve (Myval) works when placed inside a previous TAVI valve that has stopped working properly. It may help people who need another valve replacement without open-heart surgery.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This registry is for people with severe, symptomatic aortic valve narrowing who are planning a TAVI procedure (a less invasive valve replacement). It aims to better track and improve how patients do after the valve is replaced, based on how the procedure is planned and performed.
This study looks at people who already received the Myval THV heart valve implant for severe native aortic valve narrowing. It checks how patients are doing after at least 30 days of follow-up to better understand the valve’s performance.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.